WWL70 is primarily utilized in research settings as a potent and selective inhibitor of the enzyme alpha/beta-hydrolase domain 6 (ABHD6). This enzyme plays a significant role in lipid metabolism, particularly in the regulation of endocannabinoid signaling pathways. By inhibiting ABHD6, WWL70 helps researchers study the physiological and pathological roles of endocannabinoids, such as 2-arachidonoylglycerol (2-AG), in various biological processes. Its application extends to understanding conditions like inflammation, metabolic disorders, and neurological diseases, where ABHD6 activity is implicated. Additionally, WWL70 is used in pharmacological studies to explore potential therapeutic targets for diseases involving dysregulated lipid signaling.